Paper36959680
Metformin regulates expression of DNA methyltransferases through the miR-148/-152 family in non-small lung cancer cells.
Lee BB and 5 others. Clin Epigenetics, 2023. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Metformin regulates expression of DNA methyltransferases through the miR-148/-152 family in non-small lung cancer cells. Papers, record 36959680. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36959680
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Metformin regulates expression of DNA methyltransferases through the miR-148/-152 family in non-small lung cancer cells.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lung Neoplasms | Major topic |
| Carcinoma, Non-Small-Cell Lung | Major topic |
| Metformin | Major topic |
| MicroRNAs | Major topic |
| Humans | |
| 3' Untranslated Regions | |
| DNA Methylation | |
| Gene Expression Regulation, Neoplastic | |
| DNA Modification Methylases | |
| DNA | |
| Cell Line, Tumor | |
| Cell Proliferation |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25927928 | miR-148b reverses cisplatin-resistance in non-small cell cancer cells via negatively regulating DNA (cytosine-5)-methyltransferase 1(DNMT1) expression. | J Transl Med | 2015 | https://conductscience.org/library/papers/25927928 | PubMed |
| 2 | 27505047 | MicroRNA-148b Acts as a Tumor Suppressor in Cervical Cancer by Inducing G1/S-Phase Cell Cycle Arrest and Apoptosis in a Caspase-3-Dependent Manner. | Med Sci Monit | 2016 | https://conductscience.org/library/papers/27505047 | PubMed |
| 3 | 26248880 | Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues. | Diagn Pathol | 2015 | https://conductscience.org/library/papers/26248880 | PubMed |
| 4 | 23974492 | Metformin inhibits lung cancer cells proliferation through repressing microRNA-222. | Biotechnol Lett | 2013 | https://conductscience.org/library/papers/23974492 | PubMed |
| 5 | 33578894 | Metformin Reduces Histone H3K4me3 at the Promoter Regions of Positive Cell Cycle Regulatory Genes in Lung Cancer Cells. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33578894 | PubMed |
| 6 | 23318422 | MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine. | Oncogene | 2014 | https://conductscience.org/library/papers/23318422 | PubMed |
| 7 | 35117454 | MicorRNA-148b inhibits cell proliferation and facilitates cell apoptosis by regulating DNA Methyltransferase 1 in endometrial cancer. | Transl Cancer Res | 2020 | https://conductscience.org/library/papers/35117454 | PubMed |
| 8 | 29620187 | Metformin inhibits ovarian cancer via decreasing H3K27 trimethylation. | Int J Oncol | 2018 | https://conductscience.org/library/papers/29620187 | PubMed |
| 9 | 29628766 | MiR-152 functioning as a tumor suppressor that interacts with DNMT1 in nasopharyngeal carcinoma. | Onco Targets Ther | 2018 | https://conductscience.org/library/papers/29628766 | PubMed |
| 10 | 20578129 | Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. | Hepatology | 2010 | https://conductscience.org/library/papers/20578129 | PubMed |
| 11 | 24448385 | MicroRNA-148b and microRNA-152 reactivate tumor suppressor genes through suppression of DNA methyltransferase-1 gene in pancreatic cancer cell lines. | Cancer Biol Ther | 2014 | https://conductscience.org/library/papers/24448385 | PubMed |
| 12 | 28764788 | Regulation of human glioma cell apoptosis and invasion by miR-152-3p through targeting DNMT1 and regulating NF2 : MiR-152-3p regulate glioma cell apoptosis and invasion. | J Exp Clin Cancer Res | 2017 | https://conductscience.org/library/papers/28764788 | PubMed |
| 13 | 30015946 | A novel regulatory circuit of miR‑152 and DNMT1 in human bladder cancer. | Oncol Rep | 2018 | https://conductscience.org/library/papers/30015946 | PubMed |
| 14 | 20146264 | MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes. | Hepatology | 2010 | https://conductscience.org/library/papers/20146264 | PubMed |
| 15 | 30226601 | The interaction between miR‑148a and DNMT1 suppresses cell migration and invasion by reactivating tumor suppressor genes in pancreatic cancer. | Oncol Rep | 2018 | https://conductscience.org/library/papers/30226601 | PubMed |
| 16 | 28574848 | The significance of microRNA-148/152 family as a prognostic factor in multiple human malignancies: a meta-analysis. | Oncotarget | 2017 | https://conductscience.org/library/papers/28574848 | PubMed |
| 17 | 28880997 | The role of the miR-148/-152 family in physiology and disease. | Eur J Immunol | 2017 | https://conductscience.org/library/papers/28880997 | PubMed |
| 18 | 22167392 | MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in gastric cancer. | Med Oncol | 2012 | https://conductscience.org/library/papers/22167392 | PubMed |
| 19 | 27529338 | Expression and prognostic value of microRNA-26a and microRNA-148a in gastric cancer. | J Gastroenterol Hepatol | 2017 | https://conductscience.org/library/papers/27529338 | PubMed |
| 20 | 24714841 | MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in hepatocellular carcinogenesis. | Int J Oncol | 2014 | https://conductscience.org/library/papers/24714841 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41609916 | Research progress of MicroRNA in lung cancer. | Discov Oncol | 2026 | https://conductscience.org/library/papers/41609916 | PubMed |
| 41595448 | Integrative Machine Learning and Network Analysis of Skeletal Muscle Transcriptomes Identifies Candidate Pioglitazone-Responsive Biomarkers in Polycystic Ovary Syndrome. | Genes (Basel) | 2025 | https://conductscience.org/library/papers/41595448 | PubMed |
| 41394878 | Epigenetic regulation of the tumor microenvironment in lung cancer: mechanism insights and therapeutic prospects. | Front Immunol | 2025 | https://conductscience.org/library/papers/41394878 | PubMed |
| 41229781 | Research trends in epigenetic studies on lung cancer: a bibliometric and visual analysis of the past decade. | J Thorac Dis | 2025 | https://conductscience.org/library/papers/41229781 | PubMed |
| 40719815 | Targeting the molecular crosstalk between diabetes and lung cancer for therapeutic intervention. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40719815 | PubMed |
| 40643721 | Regulation and function of microRNA-152 in various types of cancers: its upstream regulators and downstream targets. | Clin Exp Med | 2025 | https://conductscience.org/library/papers/40643721 | PubMed |
| 40207763 | Metformin and its Nanoformulations in Cancer Prevention and Therapy. | Curr Pharm Des | 2025 | https://conductscience.org/library/papers/40207763 | PubMed |
| 39493516 | Metformin as a Potential Therapeutic Agent in Breast Cancer: Targeting miR-125a Methylation and Epigenetic Regulation. | Int J Mol Cell Med | 2024 | https://conductscience.org/library/papers/39493516 | PubMed |
| 39403460 | The role of DNA methylation and DNA methyltransferases (DNMTs) as potential biomarker and therapeutic target in non-small cell lung cancer (NSCLC). | Heliyon | 2024 | https://conductscience.org/library/papers/39403460 | PubMed |
| 39354464 | Non-coding RNAs as potential targets in metformin therapy for cancer. | Cancer Cell Int | 2024 | https://conductscience.org/library/papers/39354464 | PubMed |
| 38622665 | DNMT1/miR-152-3p/SOS1 signaling axis promotes self-renewal and tumor growth of cancer stem-like cells derived from non-small cell lung cancer. | Clin Epigenetics | 2024 | https://conductscience.org/library/papers/38622665 | PubMed |
| 38577020 | "Crosstalk between non-coding RNAs and transcription factor LRF in non-small cell lung cancer". | Noncoding RNA Res | 2024 | https://conductscience.org/library/papers/38577020 | PubMed |
| 38004379 | Mechanisms of Regulation of the Expression of miRNAs and lncRNAs by Metformin in Ovarian Cancer. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/38004379 | PubMed |
| 37511221 | miR-124 as a Liquid Biopsy Prognostic Biomarker in Small Extracellular Vesicles from NSCLC Patients. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37511221 | PubMed |
Genes40
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36959680
GET https://conductscience.org/api/papers/v1/36959680/references?page=2